Effect of human milk fortifier on the immunodetection and molecular mass profile of transforming growth factor-alpha

Biology of the Neonate

Volumn 77, Issue 3, 2000, Pages 156-161

  Lessaris, Karen J ^a   Forsythe, Donna W ^a   Wagner, Carol L ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Breast milk; Human milk fortifier; Transforming growth factor

Indexed keywords

MILK FAT; TAUROCHOLIC ACID; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST MILK; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; IMMUNOBLOTTING; INTESTINE FUNCTION; MOLECULAR WEIGHT; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0034062316     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014210     Document Type: Article

References (43)

1. Guerrini P: Human milk fortifiers. Acta Pacdiatr Suppl 1994;402:37-39.
2. Schanler RJ, Hurst NM, Lau C: The use of human milk and breastfeeding in premature infants; in Wagner CL, Purohit D (ed): Clinical Aspects of Human Milk and Lactation. Clinics in Perinatology, Philadelphia, Saunders, 1999, vol 26, pp 379-398.
3. Ewer AK, Durbin GM, Morgan MEI, Booth IW: Gastric emptying in preterm infants. Arch Dis Child 1994;71:F24-F27.
4. Ewer AK, Yu VYH: Gastric emptying in preterm infants: the effect of breast milk fortifier. Acta Paediatr 1996;85:1112-1115.
5. Metcalf R, Dilena B, Gibson R, Marshall P, Simmer K: How appropriate are commercially available human milk fortifiers? J Paediatr Child Health 1994;30:350-355.
6. Jocson MA, Mason EO, Schanler RJ: The effects of nutrient fortification and varying storage conditions on host defense properties of human milk. Pediatrics 1997;100:240-243.
7. Koldovsky O: Hormones and growth factors in milk. Ann Nestle [Bioactive Factors in Milk] 1996;54:105-112.
8. Wagner CL, Forsythe DW, Pittard WB III: Variation in the biochemical forms of transforming growth factor a present in human milk and secreted by human milk macrophages. Biol Neonate 1995;68:325-333.
9. Wagner CL, Forsythe DW, Wagner MT: The effect of recombinant TGF-α, human milk, and human milk macrophage media on gut epithelial proliferation is decreased in the presence of a neutralizing antibody. Biol Neonate 1998;74: 363-371.
10. Wagner CL, Forsythe DW, Pittard WB: Variation in the biochemical forms of transforming growth factor-α present in human milk and secreted by human milk macrophages. Biol Neonate 1995;68:325-333.
11. Bines JE, Walker WA: Growth factors and the development of neonatal host defense; in Mestecky J, Blair C, Ogra PL (ed): Immunology of Milk and the Neonate. Advances in Experimental Medicine and Biology. New York, Plenum Press. 1991. vol 310, pp 31-39.
12. Karnes WE: Epidermal growth factor and transforming growth factor-α; in Walsh JH, Dockray GJ (eds): Gut Peptides: Biochemistry and Physiology. New York, Raven Press, 1994, pp 553-586.
13. Seare NJ, Playford RJ: Growth factors and gut function. Proc Nutr Soc 1998;57:403-408.
14. Murphy MS: Growth factors and the gastrointestinal tract. Nutrition 1998;14:771-774.
15. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ: Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995;108:564-580.
16. Acra SA, Bulus N, Bogatcheva G, Coffey RJ, Barnard JA: Increased intestinal epithelial proliferation in metallothioneine-transforming growth factor-alpha transgenic mice. Regul Pept 1998;74:105-112.
17. Playford RJ: Peptides and gastrointestinal mucosal integrity. Gut 1995;37:595-597.
18. Egger B, Procaccino F, Lakshmanan J, Reinshagen M, Hoffman P, Patel A, Reuben W, Snanakkan S, Liu L, Barajas L, Eysselein VE: Mice lacking transforming growth factor α have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 1997;113:825-832.
19. Siafakas CG, Anatolitou F, Fusunyan RD, Walker WA, Sanderson IR: Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 1999;45:652-657.
20. Eicher DJ, Wagner CL, Condon C: Vascular endothelial growth factor (VEGF) is present in human milk. Pediatr Res 1997;41:82A.
21. Garofalo R, Chheda S, Mei F, Palkowetz KH, Rudloff HE, Schmalstieg FC, Rassin DK, Goldman AS: Interleukin-10 in human milk. Pediatr Res 1995;37:444-449.
22. Wagner CL, McPherson RJ, Forsythe DW: Differential compartmentation of TGF-α in human milk. Am Acad Breastfeeding Med 1996;2:12A.
23. McPherson RJ, Wagner CL: Compartmentalization of TGFβ1 in the fat layer of whole milk. Pediatr Res 1996;39:A.
24. Wagner CL: Effect of human milk fortifier on the immunodetection of TGF-α within human milk. Pediatr Res 1997;41:515A.
25. Okada M, Eiji O, Murakami H, Onoda N, Iwashita M, Wakai K, Tsushima T, Shizume K: Transforming growth factor-α in human milk. Life Sci 1991;48:1151-1156.
26. Luetteke NC, Michalopoulos GK, Teixido J, Gilmore R, Massague J, Lee DC: Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells. Biochemistry 1988;27: 6487-6494.
27. Riss TL, Sirbasku DA: Identification of a 15,000-molecular weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary. J Cell Physiol 1989; 138:393-404.
28. Ellis DL, Chow JC. King LE Jr: Detection of urinary TGF-alpha by HPLC and western blot in patients with melanoma. J Invest Dermatol 1990;95:27-30.
29. Miettinen PJ: Transforming growth factor-α and epidermal growth factor expression in human fetal gastrointestinal tract. Pediatr Res 1993;33:481-486.
30. McAndrew J, Rudland PS, Platt-Higgins AM, Smith JA: Immunolocalization of alpha-transforming growth factor in the developing rat mammary gland in vivo, rat mammary cells in vitro and in human breast diseases. Histochem J 1994;26:355-366.
31. Pandiella A, Massague J: Cleavage of the membrane precursor for transforming growth factor α is a regulated process. Proc Natl Acad Sci USA 1991;88:1726-1730.
32. Ignotz RA, Kelly B, Davis RJ, Massague J: Biologically active precursor for transforming growth factor type α, released by retrovirally transformed cells. Proc Natl Acad Sci USA 1986;83:6307-6311.
33. van Selten G-B, McCauley S, Humphreys-Beher, Chegini N, Schultz G: Detection of transforming growth factor-α mRNA and protein in rat lacrimal glands and characterization of transforming growth factor-α in human tears. Invest Ophthalmol Visual Sci 1996;37:166-173.
34. Briley GP, Hissong MA, Chiu ML, Lee DC: The carboxyl-terminal valine residues of proTGFα are required for its efficient maturation and intracellular routing. Mol Biol Cell 1997;8:1619-1631.
35. Mazzoni IE, Kenigsberg RL: Transforming growth factor-α's effects on astroglial-cholinergic cell interactions in the medial septal area in vitro are mediated by a2-macroglobulin. Neuroscience 1997;81:1019-1030.
36. Finley EL, King JS, Ramdsdell JS: Human pituitary somatotropes express transforming growth factor-alpha and its receptor. J Endocrinol 1994;141:547-554.
37. Diaz-Ruiz C, Asbert M, Perez-Tomas R: Immunochemical study of a transforming growth-factor-α-related protein in the chicken kidney. Kidney Int 1996;49:1053-1063.
38. Statview 4.0: Berkeley, Abacus Concepts, 1992.
39. Jensen RG, Blanc B, Patton S: Particulate constituents in human and bovine milks; in Jensen RG (ed): Handbook of Milk Composition. San Diego, Academic Press, 1995.
40. Coffey RJ, Romano M, Polk WH, Dempsey PJ: Roles for transforming growth factor-α in gastric physiology and pathophysiology. Yale J Biol Med 1992;65:693-704.
41. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ: Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995;108:564-580.
42. McClure RJ, Newell SJ: Effect of fortifying breast milk on gastric emptying. Arch Dis Child 1996;74:F60-F62.
43. Rao RK, Baker SS, Baker RD, Wagner CL, Schluter A: A comparison of infant formula and human milk fortifier with human milk in the protection of intestinal epithelial barrier function. Pediatr Res 1998;43:104A.